All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of low-density lipoprotein particle clearance | GO_0010989 | [Any process that decreases the rate, frequency or extent of low-density lipoprotein particle clearance. Low-density lipoprotein particle clearance is the process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.] |
| negative regulation of lipoprotein particle clearance | GO_0010985 | [Any process that decreases the rate, frequency, or extent of lipoprotein particle clearance. Lipoprotein particle clearance is the process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.] |
| regulation of low-density lipoprotein particle clearance | GO_0010988 | [Any process that modulates the rate, frequency or extent of low-density lipoprotein particle clearance. Low-density lipoprotein particle clearance is the process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.] |
| low-density lipoprotein particle clearance | GO_0034383 | [The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.] |
| D-allose catabolic process | GO_0019316 | [The chemical reactions and pathways resulting in the breakdown of D-allose, the D-enantiomer of allo-hexose, an aldohexose similar to glucose.] |
| allose catabolic process | GO_0046367 | [The chemical reactions and pathways resulting in the breakdown of allose, allo-hexose, an aldohexose similar to glucose, differing only in the configuration of the hydroxyl group of C-3.] |
| 3-nitrophenol nitroreductase activity | GO_0034957 | [Catalysis of the reaction: 3-nitrophenol + 2 NADH + 2 H+ = 3-hydroxyaminophenol + 2 NAD+ + H2O.] |
| oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | GO_0046857 | [Catalysis of an oxidation-reduction (redox) reaction in which a nitrogenous group, excluding NH and NH2 groups, acts as a hydrogen or electron donor and reduces NAD or NADP.] |
| fucose catabolic process | GO_0019317 | [The chemical reactions and pathways resulting in the breakdown of fucose (6-deoxygalactose).] |
| fucose metabolic process | GO_0006004 | [The chemical reactions and pathways involving fucose, or 6-deoxygalactose, which has two enantiomers, D-fucose and L-fucose.] |
| diphenyl ether 2,3-dioxygenase activity | GO_0034954 | [Catalysis of the reaction: diphenyl ether + O2 = 2,3-dihydroxydiphenyl ether.] |
| 2,3-dihydroxydiphenyl ether dioxygenase activity | GO_0034955 | [Catalysis of the reaction: 2,3-dihydroxydiphenyl ether + O2 + H2O = 2-hydroxymuconate + phenol.] |
| positive regulation of multicellular organismal process | GO_0051240 | [Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs.] |
| aminohydroquinone monooxygenase activity | GO_0034958 | [Catalysis of the reaction: aminohydroquinone + 2 e- + 2 H+ + 1/2 O2 = 1,2,4-benzenetriol + NH3.] |
| negative regulation of high-density lipoprotein particle clearance | GO_0010987 | [Any process that decreases the rate, frequency or extent of high-density lipoprotein particle clearance. High-density lipoprotein particle clearance is the process in which a high-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.] |
| endothelin maturation | GO_0034959 | [The process leading to the attainment of the full functional capacity of endothelin by conversion of Big-endothelin substrate into mature endothelin.] |
| regulation of systemic arterial blood pressure by endothelin | GO_0003100 | [The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.] |
| ubiquitin recycling | GO_0010992 | [Any process involved in the maintenance of an internal steady state of ubiquitin monomers and free ubiquitin chains at the level of the cell by recycling ubiquitin from proteasome-bound ubiquitinated intermediates.] |
| GO_0010993 | GO_0010993 | |
| free ubiquitin chain polymerization | GO_0010994 | [The process of creating free ubiquitin chains, compounds composed of a large number of ubiquitin monomers. These chains are not conjugated to a protein.] |